Crossmark

Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis

Published Online: 2024-09-02

Published Print: 2025-02

Authors

Sangamesh, Vinay C.

Alagundagi, Dhananjay B.

Jayaswamy, Pavan K.

Kuriakose, Nithin

Shetty, Praveenkumar
License Information

Text and Data Mining valid from 2024-09-02

Version of Record valid from 2024-09-02
More Information

Article History

Received: 27 May 2024

Accepted: 27 August 2024

First Online: 2 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current